Read + Share
Onder AH. Letter to the Editor: "CNS Outcomes of Osimertinib Plus Chemotherapy in Patients
With EGFR Mutation-Positive Lung Cancer Beyond Osimertinib Progression". Clin Lung Cancer 2025 Jun 20:S1525-7304(25)00142.
PMID: 40653430
|
 |
|
Onder AH. Letter to the Editor: "CNS Outcomes of Osimertinib Plus Chemotherapy in Patients
With EGFR Mutation-Positive Lung Cancer Beyond Osimertinib Progression". Clin Lung Cancer 2025 Jun 20:S1525-7304(25)00142.
PMID: 40653430
|
|
|
|